Why Society Is Running Out of Vital Medications

More

Economic laws keep most industries running smoothly. But medicine can be different—and right now it's out of control.

Tenner_Drugs_5-2_banner.jpg
Just as Japanese officials predict that disruptions from the earthquake and tsunami may last all year, The Washington Post reveals a crisis that may take more lives than the Fukushima nuclear tragedy—shortages of essential pharmaceuticals:

A record 211 medications became scarce in 2010 — triple the number in 2006 — and at least 89 new shortages have been recorded through the end of March, putting the nation on track for far more scarcities.

The paucities are forcing some medical centers to ration drugs — including one urgently needed by leukemia patients — postpone surgeries and other care, and scramble for substitutes, often resorting to alternatives that may be less effective, have more side effects and boost the risk for overdoses and other sometimes-fatal errors.

Three factors are contributing to the emergency: major companies abandoning production of drugs that have lost patent protection, tougher regulation of production by the FDA (according to the industry; the agency denies this), and especially the globalization of manufacturing:

"We've certainly reached a very global supply chain for drug products, with the active ingredients typically made outside of the United States," said Gordon Johnston, vice president for regulatory sciences at the Generic Pharmaceutical Association. "It could be Europe, India — some cases China. If there's a problem at a facility in Italy or India, it leads to disruption of the drug supply in the United States."

In one case, nine patients died because of bacterial contamination, allegedly related to a pharmacy using an unfamiliar substitute. And the missing link wasn't some advanced compound, but packaging.

The article leaves open an essential question. Nobody dies because shortages of a custom micro-controller chip delay production of a crossover wagon. (I discussed the tsunami's ripple effects here.) In ordinary manufacturing, economics can determine the right amount of future redundancy, the balance between just-in-time and just-in-case. As usual, medicine is different. The global market is starting to show cracks; the world is definitely not a flat billiard table. It's looking more and more like an out-of-balance roulette wheel. Is there anything more either manufacturers or the law can do?

Image: Wikimedia Commons

Jump to comments
Presented by

Edward Tenner is a historian of technology and culture, and an affiliate of the Center for Arts and Cultural Policy at Princeton's Woodrow Wilson School. He was a founding advisor of Smithsonian's Lemelson Center.

Get Today's Top Stories in Your Inbox (preview)

Why Do People Love Times Square?

A filmmaker asks New Yorkers and tourists about the allure of Broadway's iconic plaza


Join the Discussion

After you comment, click Post. If you’re not already logged in you will be asked to log in or register. blog comments powered by Disqus

Video

Why Do People Love Times Square?

A filmmaker asks New Yorkers and tourists about the allure of Broadway's iconic plaza

Video

A Time-Lapse of Alaska's Northern Lights

The beauty of aurora borealis, as seen from America's last frontier

Video

What Do You Wish You Learned in College?

Ivy League academics reveal their undergrad regrets

Video

Famous Movies, Reimagined

From Apocalypse Now to The Lord of the Rings, this clever video puts a new spin on Hollywood's greatest hits.

Video

What Is a City?

Cities are like nothing else on Earth.

Writers

Up
Down

More in Health

From This Author

Just In